NCT00483379View on ClinicalTrials.gov

High Dose or High Dose Frequency Study of Alglucosidase Alfa

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

July 31, 2010

Conditions
Pompe DiseaseGlycogen Storage Disease Type II (GSD-II)Glycogenesis 2 Acid Maltase Deficiency
Interventions
BIOLOGICAL

alglucosidase alfa

intravenous infusion

Trial Locations (11)

Unknown

Birmingham

Stanford

Washington D.C.

Chicago

Kansas City

Boston

Grand Rapids

Glenn Falls

Durham

Parkville Victoria

Calgary

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00483379 - High Dose or High Dose Frequency Study of Alglucosidase Alfa | Biotech Hunter | Biotech Hunter